Jaguar Health, Inc. - ROE
JAGX
Price:
$1.055
Market Cap:
$70.31K
Jaguar Health, Inc., a commercial-stage pharmaceutical firm, specializes in developing prescription therapies for both human and animal patients afflicted by gastrointestinal ailments, particularly chronic and severe diarrhea. Its operations are structured into two distinct divisions: Human Health and Animal Health. Presently, the company markets Mytesi, an approved medication providing symptomatic relief for noninfectious diarrhea experienced by adults with HIV/AIDS undergoing antiretroviral therapy. Beyond its commercial product, Jaguar Health is actively advancing Crofelemer, the active pharmaceutical ingredient in Mytesi, for a broad spectrum of additional indications. These include mana...[Read more]
Industry
Biotechnology
IPO Date
2015-05-12
Stock Exchange
NASDAQ
Ticker
JAGX
PE Ratio
[-0.02]
ROE
[770.18%]
Current Ratio
[0.50]
Dividend Yield
[0%]
Enterprise Value
[36.57M]
Dividend History
The ROE as of August 2026 (TTM) for Jaguar Health, Inc. (JAGX) is 770.18%
According to Jaguar Health, Inc.’s latest financial reports and current stock price. The company's current ROE is 770.18%. This represents a change of -1460.75% compared to the average of -56.60% of the last 4 quarters.
Jaguar Health, Inc. (JAGX) Historical ROE (quarterly & annually)
How has JAGX ROE performed in the past?
The mean historical ROE of Jaguar Health, Inc. over the last ten years is 503.63%. The current 770.18% ROE has changed 52.92% with respect to the historical average. Over the past ten years (40 quarters), JAGX's ROE was at its highest in in the September 2016 quarter at 1.25%. The ROE was at its lowest in in the June 2020 quarter at -598.32%.
Average
503.63%
Median
-278.81%
Minimum
-832.49%
Maximum
7.22%
Jaguar Health, Inc. (JAGX) ROE by Quarter and Year
Discovering the peaks and valleys of Jaguar Health, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 369.20%
Maximum Annual ROE = 7.22%
Minimum Annual Increase = -1694.53%
Minimum Annual ROE = -832.49%
| Year | ROE | Change |
|---|---|---|
| 2025 | 309.06% | -158.49% |
| 2024 | -528.37% | -36.53% |
| 2023 | -832.49% | -111.53% |
| 2022 | 7.22% | -1694.53% |
| 2021 | -452.98% | 130.47% |
| 2020 | -196.54% | -45.57% |
| 2019 | -361.09% | -39.53% |
| 2018 | -597.16% | 369.20% |
| 2017 | -127.27% | -121.20% |
| 2016 | 600.35% | -262.11% |
Jaguar Health, Inc. (JAGX) Average ROE
How has JAGX ROE performed in the past?
The current ROE of Jaguar Health, Inc. (JAGX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-350.60%
5-year avg
1.14%
10-year avg
503.63%
Jaguar Health, Inc. (JAGX) ROE vs. Peers
How is JAGX’s ROE compared to its peers?
Jaguar Health, Inc.’s ROE is greater than GRI Bio, Inc. (-199.52%), greater than CNS Pharmaceuticals, Inc. (-238.69%), greater than Biodexa Pharmaceuticals Plc (-55.81%), greater than Silo Pharma, Inc. (-88.41%), greater than InMed Pharmaceuticals Inc. (-72.72%), greater than Genprex, Inc. (-247.33%), greater than 60 Degrees Pharmaceuticals, Inc. (-200.17%), greater than Calidi Biotherapeutics, Inc. (-438.03%), greater than Can-Fite BioPharma Ltd. (-201.06%), greater than Kazia Therapeutics Ltd ADR (-116.86%),
| Company | ROE | Market cap |
|---|---|---|
| -199.52% | $137.44K | |
| -238.69% | $3.10M | |
| -55.81% | $1.19M | |
| -88.41% | $5.20M | |
| -72.72% | $2.53M | |
| -247.33% | $2.24M | |
| -200.17% | $983.99K | |
| -438.03% | $810.37K | |
| -201.06% | $1.72M | |
| -116.86% | $19.44M |
Build a custom stock screener for Jaguar Health, Inc. (JAGX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jaguar Health, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Jaguar Health, Inc. (JAGX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Jaguar Health, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Jaguar Health, Inc.'s ROE?
How is the ROE calculated for Jaguar Health, Inc. (JAGX)?
What is the highest ROE for Jaguar Health, Inc. (JAGX)?
What is the 3-year average ROE for Jaguar Health, Inc. (JAGX)?
What is the 5-year average ROE for Jaguar Health, Inc. (JAGX)?
How does the current ROE for Jaguar Health, Inc. (JAGX) compare to its historical average?